See also

References

1. ^Elks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1–.ISBN 978-1-4757-2085-3.
2. ^Ferrari RA, Chakrabarty K, Beyler AL, Wiland J (November 1978)."Suppression of sebaceous gland development in laboratory animals by 17alpha-propyltestosterone".The Journal of Investigative Dermatology.71 (5):320–323.doi:10.1111/1523-1747.ep12529809.PMID 712108.
3. ^Rasmusson GH (1986)."Chapter 18. Chemical Control of Androgen Action".Annual Reports in Medicinal Chemistry. Vol. 21. Academic Press. pp. 179–188 (183).doi:10.1016/S0065-7743(08)61128-8.ISBN 978-0-08-058365-5.
4. ^Ferrari RA, Chakrabarty K, Creange JE, Beyler AL, Potts OG, Schane HP (April 1980). "Endocrine profile of topterone, a topical antiandrogen, in three species of laboratory animals".Methods and Findings in Experimental and Clinical Pharmacology.2 (2):65–69.PMID 7339330.
5. ^Chakrabarty K, Ferrari RA, Dessingue OC, Beyler AL, Schane HP (January 1980)."Mechanism of action of 17 alpha-propyltestosterone in inhibiting hamster flank organ development".The Journal of Investigative Dermatology.74 (1):5–8.doi:10.1111/1523-1747.ep12514560.PMID 7351494.
6. ^Marsden JR, Shuster S (6 December 2012)."The Treatment of Acne".Pharmacology of the Skin II: Methods, Absorption, Metabolism and Toxicity, Drugs and Diseases. Springer Science & Business Media. pp. 490–.ISBN 978-3-642-74054-1.